The US Food and Drug Administration (FDA) has given an emergency use authorization to the first commercial laboratory test to detect neutralizing antibodies against SARS-CoV-2, the virus that causes ...

Although the 'emergency' phase of the COVID-19 pandemic may be over, it is still ongoing, and thousands of people still die from the disease every week. The virus also continues to mutate, and new ...

A recent study by Ohio State researchers shows that a new omicron subvariant of COVID-19 can be neutralized by the dual-strain vaccine, preventing the worldwide escalation of cases that was initially ...

In a recent study published in Frontiers, researchers investigated the transmission- and immunoglobulin G (IgG) viral neutralization potential of coronavirus disease 2019 (COVID-19) booster vaccine ...

Four years ago, on November 30, 2019, the first confirmed case of COVID-19 was detected in a man in Wuhan, China. It would still be over a month before the SARS-CoV-2 virus was fully identified, but ...

An antibody developed by researchers works against a wide range of COVID-19 variants and related coronaviruses, including past, present and potentially future strains. A monoclonal antibody appears ...

COVID-19 infection can be halted by compounds from Copaifera lucens leaves that block both viral entry into cells and the ...